Our products are widely recognized and trusted by users and can meet continuously changing economic and social needs for Trizol Suppliers,High Quality Rc323 ,Best Double-Stranded Dna , Pcr Plates 0.2 Ml Supplier, Endofree Plasmid Maxi Kit Manufacturer.Our tenet is "Reasonable prices, efficient production time and best service" We hope to cooperate with more customers for mutual development and benefits. The product will supply to all over the world, such as Europe, America, Australia, venezuela ,Italy ,Orlando ,When It produced, it making use of the world's major method for reliable operation, a low failure price, it appropriate for Jeddah shoppers choice. Our enterprise. s situated inside the national civilized cities, the website traffic is very hassle-free, unique geographical and financial circumstances. We pursue a "people-oriented, meticulous manufacturing, brainstorm, make brilliant" company philosophy. Strict good quality management, fantastic service, affordable cost in Jeddah is our stand around the premise of competitors. If needed, welcome to make contact with us by our web page or phone consultation, we will be delighted to serve you.
This kit is designed for the detection of host cell protein residues in process samples of biologics (such as antibodies, recombinant proteins, vaccines, etc.) expressed in CHO cell lines.
T7 RNA Polymerase (T7 RNA polymerase) is a DNA-dependent 5'→3' RNA polymerase that recognizes the T7 promoter sequence with high specificity ,can be used for transcriptional synthesis of mRNA in IVT.
The dsRNA sequence synthesized by UTP modified in vitro transcription is intended to be used as a standard for dsRNA residue detection.
The dsRNA sequence synthesized by Pseudouridine-UTP modified in vitro transcription is intended to be used as a standard for dsRNA residue detection.
The dsRNA sequence synthesized by N1-me-pseudo-UTP modified in vitro transcription is intended to be used as a standard for dsRNA residue detection.
A next-generation T7 RNA polymerase engineered to minimize dsRNA byproducts by up to 100×, enabling safer and more efficient mRNA therapeutics.
